{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:43:39Z","timestamp":1771483419482,"version":"3.50.1"},"reference-count":105,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2015.00025","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T14:36:36Z","timestamp":1432046196000},"source":"Crossref","is-referenced-by-count":39,"title":["Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart Failure"],"prefix":"10.3389","volume":"2","author":[{"given":"Traci L.","family":"Parry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason H.","family":"Melehani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Ranek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monte S.","family":"Willis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2015,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"H544","DOI":"10.1152\/ajpheart.00815.2011","article-title":"Current perspectives on cardiac amyloidosis","volume":"302","author":"Guan","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B2","first-page":"100","article-title":"[The effect of the nervous system on the sensitivity of rat ovaries to lactogenic hormone]","volume":"12","author":"Kirshenblat Ia","year":"1966","journal-title":"Probl Endokrinol Gormonoter"},{"key":"B3","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidoses","volume":"337","author":"Falk","year":"1997","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/0735-1097(89)90254-4","article-title":"Doppler characterization of left ventricular diastolic function in cardiac amyloidosis","volume":"13","author":"Klein","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1136\/hrt.78.1.74","article-title":"Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes","volume":"78","author":"Dubrey","year":"1997","journal-title":"Heart"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1161\/01.RES.0000126569.75419.74","article-title":"Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress","volume":"94","author":"Brenner","year":"2004","journal-title":"Circ Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijcard.2009.04.044","article-title":"Systemic and microvascular oxidative stress induced by light chain amyloidosis","volume":"145","author":"Migrino","year":"2010","journal-title":"Int J Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"H2305","DOI":"10.1152\/ajpheart.00503.2011","article-title":"Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins","volume":"301","author":"Migrino","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1038\/cddis.2010.75","article-title":"Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture","volume":"1","author":"Sikkink","year":"2010","journal-title":"Cell Death Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1161\/CIRCULATIONAHA.109.879510","article-title":"Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy","volume":"121","author":"Gianni","year":"2010","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.jacc.2015.01.031","article-title":"Cofilin-2 phosphorylation and sequestration in myocardial aggregates: novel pathogenetic mechanisms for idiopathic dilated cardiomyopathy","volume":"65","author":"Subramanian","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF02700622","article-title":"Cofilin-mediated neurodegeneration in Alzheimer\u00e2\u20ac\u2122s disease and other amyloidopathies","volume":"35","author":"Maloney","year":"2007","journal-title":"Mol Neurobiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4161\/bioa.22549","article-title":"The role of the cofilin-actin rod stress response in neurodegenerative diseases uncovers potential new drug targets","volume":"2","author":"Munsie","year":"2012","journal-title":"Bioarchitecture"},{"key":"B14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/1389203715666140331111518","article-title":"Chaperones and cardiac misfolding protein diseases","volume":"15","author":"Christians","year":"2014","journal-title":"Curr Protein Pept Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/cvr\/cvu060","article-title":"Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes","volume":"102","author":"Mehta","year":"2014","journal-title":"Cardiovasc Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/CIRCULATIONAHA.105.570200","article-title":"Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism","volume":"113","author":"Anderson","year":"2006","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-biochem-062209-093836","article-title":"Protein folding and modification in the mammalian endoplasmic reticulum","volume":"80","author":"Braakman","year":"2011","journal-title":"Annu Rev Biochem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev.genom.7.080505.115737","article-title":"Protein misfolding and human disease","volume":"7","author":"Gregersen","year":"2006","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.2174\/1568026611212220002","article-title":"Protein misfolding in disease and small molecule therapies","volume":"12","author":"Gomes","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"B21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/0-387-25919-8_2","article-title":"The generic nature of protein folding and misfolding","volume-title":"Protein Misfolding, Aggregation, and Conformational Diseases","author":"Dobson","year":"2006"},{"key":"B22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nsb0197-10","article-title":"From Levinthal to pathways to funnels","volume":"4","author":"Dill","year":"1997","journal-title":"Nat Struct Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.sbi.2004.01.009","article-title":"Theory of protein folding","volume":"14","author":"Onuchic","year":"2004","journal-title":"Curr Opin Struct Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev-biophys-051309-103835","article-title":"Theoretical perspectives on protein folding","volume":"39","author":"Thirumalai","year":"2010","journal-title":"Annu Rev Biophys"},{"key":"B25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrm2144","article-title":"The folding and evolution of multidomain proteins","volume":"8","author":"Han","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"Suppl","key":"B26","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrm1742","article-title":"Opinion: what is the role of protein aggregation in neurodegeneration?","volume":"6","author":"Ross","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"10132","DOI":"10.1073\/pnas.0401900101","article-title":"Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis","volume":"101","author":"Sanbe","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1161\/01.RES.0000067471.95890.5C","article-title":"Myocytes die by multiple mechanisms in failing human hearts","volume":"92","author":"Kostin","year":"2003","journal-title":"Circ Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.107.763870","article-title":"Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy","volume":"117","author":"Tannous","year":"2008","journal-title":"Circulation"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1161\/CIRCULATIONAHA.107.750232","article-title":"Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure","volume":"117","author":"Pattison","year":"2008","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"30057","DOI":"10.1074\/jbc.M100142200","article-title":"Oxidative modification and inactivation of the proteasome during coronary occlusion\/reperfusion","volume":"276","author":"Bulteau","year":"2001","journal-title":"J Biol Chem"},{"key":"B33","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1161\/CIRCRESAHA.112.270983","article-title":"Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia-reperfusion injury in mice","volume":"111","author":"Tian","year":"2012","journal-title":"Circ Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1161\/CIRCULATIONAHA.110.942250","article-title":"Hold me tight: role of the heat shock protein family of chaperones in cardiac disease","volume":"122","author":"Willis","year":"2010","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.yjmcc.2010.09.004","article-title":"Selective degradation of aggregate-prone CryAB mutants by HSPB1 is mediated by ubiquitin-proteasome pathways","volume":"49","author":"Zhang","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e5351","DOI":"10.1371\/journal.pone.0005351","article-title":"Protective effect of geranylgeranylacetone via enhancement of HSPB8 induction in desmin-related cardiomyopathy","volume":"4","author":"Sanbe","year":"2009","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0165-6147(00)01575-3","article-title":"Pharmacological chaperones: a new twist on receptor folding","volume":"21","author":"Morello","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1172\/JCI8688","article-title":"Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants","volume":"105","author":"Morello","year":"2000","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1172\/JCI119098","article-title":"Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist","volume":"98","author":"Serradeil-Le Gal","year":"1996","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2174\/138955708785132783","article-title":"Protein misfolding in conformational disorders: rescue of folding defects and chemical chaperoning","volume":"8","author":"Leandro","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.2174\/092986712800269236","article-title":"Transthyretin deposition in familial amyloidotic polyneuropathy","volume":"19","author":"Saraiva","year":"2012","journal-title":"Curr Med Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1517\/13543784.2014.922541","article-title":"An overview of drugs currently under investigation for the treatment of transthyretin-related hereditary amyloidosis","volume":"23","author":"Obici","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"B43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jmb.2011.12.060","article-title":"The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug","volume":"421","author":"Johnson","year":"2012","journal-title":"J Mol Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1021\/jm0708735","article-title":"Biochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors","volume":"51","author":"Johnson","year":"2008","journal-title":"J Med Chem"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1002\/anie.200351179","article-title":"Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action","volume":"42","author":"Razavi","year":"2003","journal-title":"Angew Chem Int Ed Engl"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1007\/s00415-013-7051-7","article-title":"Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy","volume":"260","author":"Coelho","year":"2013","journal-title":"J Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s40265-014-0260-2","article-title":"Tafamidis: a review of its use in familial amyloid polyneuropathy","volume":"74","author":"Scott","year":"2014","journal-title":"Drugs"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12561","article-title":"The effect of tafamidis on the QT interval in healthy subjects","author":"Klamerus","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"97ra81","DOI":"10.1126\/scitranslmed.3002473","article-title":"Potent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity","volume":"3","author":"Alhamadsheh","year":"2011","journal-title":"Sci Transl Med"},{"key":"B51","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood.V86.3.855.855","article-title":"New drug therapy of amyloidoses: resorption of AL-type deposits with 4\u00e2\u20ac\u2122-iodo-4\u00e2\u20ac\u2122-deoxydoxorubicin","volume":"86","author":"Gianni","year":"1995","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1073\/pnas.92.7.2959","article-title":"Interaction of the anthracycline 4\u00e2\u20ac\u2122-iodo-4\u00e2\u20ac\u2122-deoxydoxorubicin with amyloid fibrils: inhibition of amyloidogenesis","volume":"92","author":"Merlini","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"B53","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1096\/fj.02-0764com","article-title":"4\u00e2\u20ac\u2122-iodo-4\u00e2\u20ac\u2122-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters","volume":"17","author":"Cardoso","year":"2003","journal-title":"FASEB J"},{"key":"B54","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1096\/fj.05-4509com","article-title":"Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model","volume":"20","author":"Cardoso","year":"2006","journal-title":"FASEB J"},{"key":"B55","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.bbadis.2008.05.005","article-title":"Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of familial amyloidotic polyneuropathy","volume":"1782","author":"Macedo","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1073\/pnas.1220326110","article-title":"Insights into antiamyloidogenic properties of the green tea extract (-)-epigallocatechin-3-gallate toward metal-associated amyloid-beta species","volume":"110","author":"Hyung","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B57","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jmb.2012.01.013","article-title":"Structural properties of EGCG-induced, nontoxic Alzheimer\u00e2\u20ac\u2122s disease abeta oligomers","volume":"421","author":"Lopez del Amo","year":"2012","journal-title":"J Mol Biol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00392-012-0463-z","article-title":"Green tea halts progression of cardiac transthyretin amyloidosis: an observational report","volume":"101","author":"Kristen","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejps.2010.06.010","article-title":"Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate","volume":"41","author":"Dube","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00228-008-0610-7","article-title":"Hepatotoxicity from green tea: a review of the literature and two unpublished cases","volume":"65","author":"Mazzanti","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.abb.2009.02.013","article-title":"Binding and stabilization of transthyretin by curcumin","volume":"485","author":"Pullakhandam","year":"2009","journal-title":"Arch Biochem Biophys"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1016\/j.febslet.2011.06.030","article-title":"Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation","volume":"585","author":"Ferreira","year":"2011","journal-title":"FEBS Lett"},{"key":"B63","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbadis.2012.10.007","article-title":"Dietary curcumin counteracts extracellular transthyretin deposition: insights on the mechanism of amyloid inhibition","volume":"1832","author":"Ferreira","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B64","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nrn3638","article-title":"Inflammasomes in the CNS","volume":"15","author":"Walsh","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"B65","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.immuni.2013.08.037","article-title":"Mechanisms of NOD-like receptor-associated inflammasome activation","volume":"39","author":"Wen","year":"2013","journal-title":"Immunity"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2014.01.063","article-title":"Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation","volume":"156","author":"Cai","year":"2014","journal-title":"Cell"},{"key":"B68","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/ni.2913","article-title":"The adaptor ASC has extracellular and \u00e2\u20ac\u02dcprionoid\u00e2\u20ac\u2122 activities that propagate inflammation","volume":"15","author":"Franklin","year":"2014","journal-title":"Nat Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","article-title":"Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes","volume":"156","author":"Lu","year":"2014","journal-title":"Cell"},{"key":"B70","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N Engl J Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1742-2094-9-199","article-title":"Pro-inflammatory interleukin-18 increases Alzheimer\u00e2\u20ac\u2122s disease-associated amyloid-beta production in human neuron-like cells","volume":"9","author":"Sutinen","year":"2012","journal-title":"J Neuroinflammation"},{"key":"B73","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10238-005-0071-6","article-title":"Hereditary periodic fever and reactive amyloidosis","volume":"5","author":"van der Hilst","year":"2005","journal-title":"Clin Exp Med"},{"issue":"542","key":"B74","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1016\/j.echo.2009.01.022","article-title":"A case of systemic amyloidosis following ankylosing spondylitis associated with congestive heart failure","volume":"22","author":"Ha","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"B75","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.revmed.2013.05.003","article-title":"[Cardiac amyloidosis: a case series of 14 patients, description and prognosis]","volume":"34","author":"Isabel","year":"2013","journal-title":"Rev Med Interne"},{"key":"B76","doi-asserted-by":"publisher","first-page":"823093","DOI":"10.1155\/2014\/823093","article-title":"Therapeutic benefits of tocilizumab vary in different organs of a patient with AA amyloidosis","volume":"2014","author":"Matsui","year":"2014","journal-title":"Case Rep Nephrol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"16115","DOI":"10.1073\/pnas.1306621110","article-title":"Pathogenetic mechanisms of amyloid A amyloidosis","volume":"110","author":"Simons","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B78","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1080\/13506120802524676","article-title":"Amyloidosis is frequently undetected in patients with rheumatoid arthritis","volume":"15","author":"Koivuniemi","year":"2008","journal-title":"Amyloid"},{"key":"B79","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3109\/13506129.2011.636460","article-title":"Tocilizumab improves cardiac disease in a hemodialysis patient with AA amyloidosis secondary to rheumatoid arthritis","volume":"19","author":"Hattori","year":"2012","journal-title":"Amyloid"},{"key":"B80","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3109\/03009742.2011.569754","article-title":"Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents","volume":"40","author":"Wada","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4049\/jimmunol.1100500","article-title":"Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice","volume":"187","author":"Ather","year":"2011","journal-title":"J Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1007\/s00018-012-1140-0","article-title":"NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1beta and neuronal toxicity","volume":"69","author":"Hafner-Bratkovic","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"B83","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.4049\/jimmunol.1002843","article-title":"Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway","volume":"186","author":"Niemi","year":"2011","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1128\/IAI.02370-14","article-title":"Toll-like receptor 2 and NLRP3 cooperate to recognize a functional bacterial amyloid, curli","volume":"83","author":"Rapsinski","year":"2015","journal-title":"Infect Immun"},{"key":"B87","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"key":"B88","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1113\/expphysiol.2012.068338","article-title":"The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1beta","volume":"98","author":"Bracey","year":"2013","journal-title":"Exp Physiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1515\/cclm-2012-0600","article-title":"Association of nucleotide-binding oligomerization domain-like receptor 3 inflammasome and adverse clinical outcomes in patients with idiopathic dilated cardiomyopathy","volume":"51","author":"Luo","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1097\/00003246-199907000-00018","article-title":"Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function","volume":"27","author":"Cain","year":"1999","journal-title":"Crit Care Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1161\/CIRCULATIONAHA.107.731877","article-title":"Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis","volume":"117","author":"Ikonomidis","year":"2008","journal-title":"Circulation"},{"key":"B92","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)","volume":"162","author":"Ridker","year":"2011","journal-title":"Am Heart J"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.bbadis.2013.04.011","article-title":"Functional diversity of protein fibrillar aggregates from physiology to RNA granules to neurodegenerative diseases","volume":"1832","author":"Furukawa","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B94","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cell.2012.06.019","article-title":"The RIP1\/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis","volume":"150","author":"Li","year":"2012","journal-title":"Cell"},{"key":"B95","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/cvr\/cvu146","article-title":"RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction","volume":"103","author":"Luedde","year":"2014","journal-title":"Cardiovasc Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00395-012-0270-8","article-title":"Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo","volume":"107","author":"Oerlemans","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cytogfr.2013.12.013","article-title":"Necrosis-dependent and independent signaling of the RIP kinases in inflammation","volume":"25","author":"Moriwaki","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"B98","first-page":"140","article-title":"Neddylation and deneddylation in cardiac biology","volume":"4","author":"Kandala","year":"2014","journal-title":"Am J Cardiovasc Dis"},{"key":"B99","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0092-8674(94)90578-9","article-title":"Arabidopsis COP9 is a component of a novel signaling complex mediating light control of development","volume":"78","author":"Wei","year":"1994","journal-title":"Cell"},{"key":"B100","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev.cellbio.19.111301.112449","article-title":"The COP9 signalosome","volume":"19","author":"Wei","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nature13566","article-title":"Crystal structure of the human COP9 signalosome","volume":"512","author":"Lingaraju","year":"2014","journal-title":"Nature"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1161\/CIRCULATIONAHA.111.048934","article-title":"COP9 signalosome regulates autophagosome maturation","volume":"124","author":"Su","year":"2011","journal-title":"Circulation"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1161\/CIRCHEARTFAILURE.113.000338","article-title":"The COP9 signalosome is required for autophagy, proteasome-mediated proteolysis, and cardiomyocyte survival in adult mice","volume":"6","author":"Su","year":"2013","journal-title":"Circ Heart Fail"},{"key":"B104","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.str.2010.02.008","article-title":"Structural insights into the COP9 signalosome and its common architecture with the 26S proteasome lid and eIF3","volume":"18","author":"Enchev","year":"2010","journal-title":"Structure"},{"key":"B105","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1111\/j.1742-4658.2005.04807.x","article-title":"Consequences of COP9 signalosome and 26S proteasome interaction","volume":"272","author":"Huang","year":"2005","journal-title":"FEBS J"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T10:18:59Z","timestamp":1599041939000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.frontiersin.org\/Molecular_Cardiology\/10.3389\/fcvm.2015.00025\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,19]]},"references-count":105,"URL":"https:\/\/doi.org\/10.3389\/fcvm.2015.00025","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,19]]}}}